肺结核合并糖尿病流行现状及其危险因素研究进展
Research Progress on Prevalence and Risk Factors of Pulmonary Tuberculosis Complicated with Diabetes
DOI: 10.12677/acm.2026.1662352, PDF,   
作者: 顾红丽:内蒙古民族大学第二临床医学院内分泌科,内蒙古 呼伦贝尔;张春香*:内蒙古林业总医院内分泌科,内蒙古 呼伦贝尔
关键词: 肺结核糖尿病流行病学现状分析危险因素防控措施Tuberculosis Diabetes Epidemiology Current Situation Analysis Risk Factors Prevention and Control Measures
摘要: 肺结核与糖尿病都属于慢性病,对于全球公共卫生带来严峻挑战,在疾病的发病上,常常联合发作,联合发病进一步增加负担以及治疗难度,所以关于疾病发病情况以及风险因素的研究也一直是热点。本文通过综述形式,对于肺结核合并糖尿病流行现状进行整理,从相关文献掌握疾病流行特征,明确疾病风险,并且针对该病相关危险因素整理,以此提出一些个人认为有效的防控干预措施,为临床干预提供一定参考借鉴。
Abstract: Tuberculosis and diabetes are both chronic diseases, which pose serious challenges to global public health. In terms of disease incidence, they often co attack, which further increases the burden and treatment difficulty. Therefore, research on disease incidence and risk factors has always been a hot spot. In this paper, the epidemic situation of pulmonary tuberculosis combined with diabetes is sorted out in the form of review, the epidemic characteristics of the disease are grasped from relevant literature, the disease risk is clarified, and the relevant risk factors of the disease are sorted out, so as to put forward some prevention and control interventions that individuals think are effective, providing some reference for clinical intervention.
文章引用:顾红丽, 张春香. 肺结核合并糖尿病流行现状及其危险因素研究进展[J]. 临床医学进展, 2026, 16(6): 1401-1406. https://doi.org/10.12677/acm.2026.1662352

参考文献

[1] 吴璇, 张艳秋, 徐吉英, 等. 2019-2023年河南省肺结核合并糖尿病患者治疗转归影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 425-431.
[2] 张买, 杨敬源, 余琴, 等. 2017-2022年毕节市肺结核合并糖尿病患者流行特征及治疗转归影响因素[J]. 中国感染控制杂志, 2025, 24(3): 402-409.
[3] 徐静, 罗萍, 贺晓新. 肺结核合并糖尿病与单纯肺结核患者流行特征对比分析[J]. 中国防痨杂志, 2022, 44(5): 494-499.
[4] Alemu, A., Seid, G., Diriba, G., Hailu, M., Dange, B., Moga, S., et al. (2025) Prevalence and Associated Factors of Tuberculosis among Diabetic Patients Attending Public Health Facilities in Ethiopia: A Multicenter Study. Archives of Public Health, 83, 1-15. [Google Scholar] [CrossRef] [PubMed]
[5] Ntinginya, N.E., te Brake, L., Sabi, I., Chamba, N., Kilonzo, K., Laizer, S., et al. (2022) Rifapentine and Isoniazid for Prevention of Tuberculosis in People with Diabetes (PROTID): Protocol for a Randomised Controlled Trial. Trials, 23, Article No. 480. [Google Scholar] [CrossRef] [PubMed]
[6] 赵燕, 张宏伟, 邓亚丽, 等. 陕西省肺结核合并糖尿病登记率及趋势分析(2017-2023年) [J]. 国际流行病学传染病学杂志, 2026, 53(1): 10-16.
[7] 孔德亮, 税义超, 王向柳, 等. 2016-2022年重庆市肺结核合并糖尿病人群特征, 发病趋势及治疗转归[J]. 中国公共卫生, 2025, 41(1): 80-87.
[8] 张嘉怡, 吴谦. 肺结核合并糖尿病患者流行特征及对治疗结局的影响[J]. 临床医学进展, 2025, 15(10): 200-208.
[9] 蔡清河, 符慧, 陈蕊明, 等. 2016-2022年汕头市肺结核合并糖尿病患者临床特征及其影响因素分析[J]. 中国防痨杂志, 2024, 46(8): 926-934.
[10] Suwirda, C., Zakaria, R., Nurjannah, N., Zahara, M. and Rani, H.A. (2025) Risk Factors for Pulmonary Tuberculosis in Diabetes Mellitus Patients. Indonesian Journal of Global Health Research, 7, 235-248. [Google Scholar] [CrossRef
[11] Hewage, S., Somasundaram, N., Ratnasamy, V., Ranathunga, I., Fernando, A., Perera, I., et al. (2021) Active Screening of Patients with Diabetes Mellitus for Pulmonary Tuberculosis in a Tertiary Care Hospital in Sri Lanka. PLOS ONE, 16, e0249787. [Google Scholar] [CrossRef] [PubMed]
[12] 王铂, 马玉宝, 郭强, 等. 2018-2021年甘肃省肺结核合并糖尿病患者特征及治疗转归影响因素分析[J]. 疾病监测, 2024, 39(6): 771.
[13] 郭晶, 庞加磊, 高卫卫, 等. 2019-2021年南京地区成人活动性肺结核合并糖尿病患者表型耐药特征分析[J]. 中国防痨杂志, 2024, 46(1): 62-69.
[14] 马艳, 杜建, 高微微, 等. 复治肺结核合并糖尿病现状及影响因素[J]. 中国公共卫生, 2021, 37(9): 1400-1404.
[15] 徐晓梅, 冯连彩, 谭薇. 日照市复治肺结核住院患者合并糖尿病的临床特征及危险因素分析[J]. 遵义医科大学学报, 2023, 46(10): 984-989.
[16] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会, 等. 中国老年糖尿病诊疗指南(2024版) [J]. 协和医学杂志, 2024, 15(4): 771-800.